Clinical Trials Browser

Malignant Solid Tumor × pembrolizumab × 90 days × Clear all

NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Malignant Solid Tumor